Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure.
Intensive Care Med
; 22(9): 909-15, 1996 Sep.
Article
em En
| MEDLINE
| ID: mdl-8905425
ABSTRACT
OBJECTIVE:
To determine the efficiency of intravenous infusion of octreotide in the treatment of patients with severe pancreatitis and pulmonary failure.DESIGN:
Prospective, case-control study.SETTING:
Intensive care unit of a university hospital. PATIENTS Treatment group 39 patients with necrotizing pancreatitis were selected for the study. In all, pulmonary failure developed under conservative treatment and surgical intervention had been necessary because of local (abscess, necrosis) or systemic (systemic inflammatory response syndrome) complications. The outcome was prospectively followed up until death or discharge from the hospital. CONTROL GROUP 54 case-control matched patients with acute necrotizing pancreatitis and pulmonary failure, who had not been treated with octreotide. INTERVENTION Each patient in the treatment group received 100 micrograms intravenous octreotide three times daily for 10 days, in addition to the standard intensive care therapy.RESULTS:
The groups (octreotide group, control group) were highly comparable with regard to age (mean age 54, 51 years), sex, severity of illness (Acute Physiology and Chronic Health Evaluation II score 27, 27), etiology of pancreatitis, and pretreatment at the time of admission to the intensive care unit. There was no difference in the development of renal, hepatic, gastrointestinal, hemostatic, neurologic, or local complications. But the frequency of the adult respiratory distress syndrome (18 vs 40%; p < 0.05) and circulatory shock (51 vs 87%; p < 0.05) was significantly lower in the treatment group. Furthermore, mortality was 26% (10 of 39 patients) in the octreotide group and 61% (33 of 54 patients) in the control group (p < 0.01).CONCLUSION:
The results of our case-control study showed a beneficial effect of octreotide in patients with severe necrotizing pancreatitis and pulmonary failure. Based on these data, a prospective, double-blind, placebo-controlled study should be performed to evaluate these results.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Insuficiência Respiratória
/
Fármacos Gastrointestinais
/
Octreotida
/
Pancreatite Necrosante Aguda
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Intensive Care Med
Ano de publicação:
1996
Tipo de documento:
Article
País de afiliação:
Alemanha